Radiotherapy of Squamous Cell Carcinoma of the Anal Canal: Search for Optimal Solutions

The increase in the number of cured patients with squamous cell anal carcinoma and the quality of life is directly related to the improvement of radiotherapy departments technical equipment in oncological clinics.

Main goals are more accurate determination of the tumor volume by using modern diagnostic methods, and creating the possibility of maximum impact on the tumor and identified affected lymph nodes while limiting dose to organs at risk.

During the period from 2000 to 2015, 301 patients with squamous cell anal carcinoma, stage _T1-4N_0-3M_0-1, were complex treated by radiation therapy with 2DRT, 3DCRT, or IMRT/VMAT in a total dose of 50-60 Gy.

The use of IMRT / VMAT in comparison with conformal radiation therapy allowed to improve: immediate results (complete tumor regression) 67.5 vs 55.6 % (p = 0.071) and 3-year long-term treatment results (overall survival) 92.9 vs 88.2 % (p = 0.05), respectively, with a tendency for the reliability of local-regional control 89.9 vs 81.6 % (p = 0.179).

The use of radiation therapy in its modern version, using modern imaging methods allowed to achieve high immediate and long-term oncological results with the definition of the boundaries of the tumor lesion and summing the planned dose to the primary tumor and the affected lymph nodes.

1. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer. 2004;101:281-8. DOI: 10.1002/cncr.20364.

2. Wilkinson JR, Morris EJ, Downing A, Finan PJ, Aravani A, Thomas JD, Sebag-Montefiore D. The rising incidence of anal cancer in England 19902010: a population-based study. Colorectal Dis. 2014;16:234-9. DOI: 10.1111/codi.12553.

3. James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol. 2013;14:516-24. DOI: 10.1016/S1470-2045(13)70086-X.

4. Rybakov EG. Diagnosis and treatment of epidermoid neoplasms of the anoperianal region. Dr. Sci. Med. 2008. (In Russ.).

5. Valentini V, et al. Evidence and research in rectal cancer. Radiotherapy Oncology. 2008;87:449-74.

6. Nigro ND, Seydel HG, Considine B Jr, et al. Combined radiotherapy and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983;51:1826-9.

7. Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/ mitomycin versus fluorouracil/ cisplatin. J Clin Oncol. 2012;30:4344-51.

8. Ali Hosni, et al. The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy. Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. Oncotarget, 2018;9(29):20439-50.

9. Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86:27-33. DOI: 10.1016/j.ijrobp.2012.09.023.

10. Cozzi L. Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. BMC Cancer. 2014;14(1):833.

11. Tkachev SI, Barsukov Yu.A., Trofimova OP, Nazarenko AV, Tsaryuk VF, Glebovskaya VV. Polyradiomodification is a promising option for improving the results of combined treatment of patients with malignant tumors. Radiation Oncology and Nuclear Medicine. 2011;(1):7-13. (In Russ.).

12. Goldobenko GV, Knysh VI, Tkachev SI, Timofeev YuM, Perevoshchikov AG, Yuryeva TYu. Thermoradiotherapy of squamous cell carcinoma of the rectum. Soviet Medicine. 1987;(12):5-8. (In Russ.).

13. Malikhov AG. Combined and comprehensive treatment of patients with squamous cell carcinoma of the anal canal. PhD Med. 2003. (In Russ.).

14. Tkachev SI. The combined use of radiation therapy and local hyperthermia in the treatment of locally advanced neoplasms. Dr. Sci. Med. 1994. (In Russ.).

15. Mell LK, Schomas DA, Salama JK, et al. Association between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Anal Cancer Patients Treated with Concurrent Chemotherapy and Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(5):1431-7.

16. Freese C, Sudhoff M, Lewis LM, et al. The Volume of PET-Defined, Active Bone Marrow Spared Predicts Acute Hematologic Toxicities in Anal Cancer Patients Receiving Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. October 1, 2017;99(2)Suppl.:E148-E149.

17. Gay HA, Barthold HJ, O’Meara E, et al. Pelvic Normal Tissue Contouring Guidelines for Radiation Therapy: A Radiation Therapy Oncology Group Consensus Panel Atlas. Int J Radiat Oncol Biol Phys. 2012;83(3):353-62. DOI: 10.1016/j.ijrobp.2012.01.023.

18. Mahantshetty U, Krishnatry R, Chaudhari S, Kanaujia A, et al. Comparison of 2 Contouring Methods of Bone Marrow on CT and Correlation with Hematological Toxicities in Non-Bone-Marrow-Sparing Pelvic Intensity-Modulated Radiotherapy with Concurrent Cisplatin for Cervical Cancer. Int J Gynecol Cancer. 2012;22(8):1427-34.

19. Myerson RJ, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009;74:824-30.

20. Glebovskaya VV, Tkachev SI, Rasulov AO. The results of the complex treatment of patients with squamous cell carcinoma of the anal canal using advanced radiotherapy technologies. Problems in Oncology. 2015;(4):656-60. (In Russ.).

21. Glebovskaya VV, Tkachev SI, Nazarenko AV, Trofimova OP, Bulychkin PV, Timoshkina EV, et al. Is stress-fracture a rare complication? Own observations with modern diagnostic methods and radiation therapy. Medical Alphabet. A series of magazines «Diagnosis and Oncotherapy.» 2018;1(10). (In Russ.).

22. Lawton C, Michalski J, El-Naqa I, Buyyounouski M, Lee WR, Menard CM. RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74:383-7.

23. Tkachev SI, Glebovskaya VV, Yazhgunovich IP. Modern technology for the preparation and conduct of radiation therapy for patients with squamous cell carcinoma of the anal canal. Oncological Coloproctology. 2013;(3):48-53. (In Russ.).

24. Тимофеев ЮМ. Злокачественные опухоли анального канала. Дисс. докт. мед. наук. 1990. [Timofeev YuM. Malignant tumors of the anal canal. Dr. Sci. Med. 1990. (In Russ.)].

25. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized Intergroup Study. J Clin Oncol 1996;14:2527-39.

26. Ajani JA,Winter KA, Gunderson LL, et al. US Intergroup Anal Carcinoma Trial: Tumor diameter predicts for colostomy. J Clin Oncol. 2009;27:1116-21.

27. Tepper JE, Wang AZ. Improving local control in rectal cancer: radiation sensitizers or radiation dose. J Clin Oncol. 2010(28):1623-32.